-
1
-
-
20244372858
-
Hemochromatosis and iron-overload screening in a racially diverse population
-
Adams P. C., Reboussin D. M., Barton J. C. et al. (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. Med. 352, 1769–1778.
-
(2005)
N. Engl. J. Med.
, vol.352
, pp. 1769-1778
-
-
Adams, P.C.1
Reboussin, D.M.2
Barton, J.C.3
-
2
-
-
46149107512
-
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta
-
Adlard P. A., Cherny R. A., Finkelstein D. I. et al. (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59, 43–55.
-
(2008)
Neuron
, vol.59
, pp. 43-55
-
-
Adlard, P.A.1
Cherny, R.A.2
Finkelstein, D.I.3
-
3
-
-
79952610782
-
Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease
-
Adlard P. A., Bica L., White A. R. et al. (2011) Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease. PLoS ONE, 6, e17669.
-
(2011)
PLoS ONE
, vol.6
-
-
Adlard, P.A.1
Bica, L.2
White, A.R.3
-
4
-
-
0036670712
-
Aggregation and neurotoxicity of alpha-synuclein and related peptides
-
el-Agnaf O. M. and Irvine G. B. (2002) Aggregation and neurotoxicity of alpha-synuclein and related peptides. Biochem. Soc. Trans. 30, 559–565.
-
(2002)
Biochem. Soc. Trans.
, vol.30
, pp. 559-565
-
-
el-Agnaf, O.M.1
Irvine, G.B.2
-
5
-
-
84903368557
-
H63D mutation in hemochromatosis alters cholesterol metabolism and induces memory impairment
-
Ali-Rahmani F., Grigson P. S., Lee S., Neely E., Connor J. R. and Schengrund C. L. (2014) H63D mutation in hemochromatosis alters cholesterol metabolism and induces memory impairment. Neurobiol. Aging 35, 1511, e1511–1512.
-
(2014)
Neurobiol. Aging
, vol.35
, pp. 1511-1512
-
-
Ali-Rahmani, F.1
Grigson, P.S.2
Lee, S.3
Neely, E.4
Connor, J.R.5
Schengrund, C.L.6
-
6
-
-
43249100611
-
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
-
Amit T., Avramovich-Tirosh Y., Youdim M. B. and Mandel S. (2008) Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators. FASEB J. 22, 1296–1305.
-
(2008)
FASEB J.
, vol.22
, pp. 1296-1305
-
-
Amit, T.1
Avramovich-Tirosh, Y.2
Youdim, M.B.3
Mandel, S.4
-
9
-
-
77953810574
-
Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage
-
Arosio P. and Levi S. (2010) Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim. Biophys. Acta 1800, 783–792.
-
(2010)
Biochim. Biophys. Acta
, vol.1800
, pp. 783-792
-
-
Arosio, P.1
Levi, S.2
-
10
-
-
67349100157
-
Ferritins: a family of molecules for iron storage, antioxidation and more
-
Arosio P., Ingrassia R. and Cavadini P. (2009) Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim. Biophys. Acta 1790, 589–599.
-
(2009)
Biochim. Biophys. Acta
, vol.1790
, pp. 589-599
-
-
Arosio, P.1
Ingrassia, R.2
Cavadini, P.3
-
11
-
-
7244242355
-
T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores
-
Atasoy H. T., Nuyan O., Tunc T., Yorubulut M., Unal A. E. and Inan L. E. (2004) T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurol. India 52, 332–337.
-
(2004)
Neurol. India
, vol.52
, pp. 332-337
-
-
Atasoy, H.T.1
Nuyan, O.2
Tunc, T.3
Yorubulut, M.4
Unal, A.E.5
Inan, L.E.6
-
12
-
-
84878398613
-
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
-
Ayton S., Lei P., Duce J. A., Wong B. X., Sedjahtera A., Adlard P. A., Bush A. I. and Finkelstein D. I. (2013) Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann. Neurol. 73, 554–559.
-
(2013)
Ann. Neurol.
, vol.73
, pp. 554-559
-
-
Ayton, S.1
Lei, P.2
Duce, J.A.3
Wong, B.X.4
Sedjahtera, A.5
Adlard, P.A.6
Bush, A.I.7
Finkelstein, D.I.8
-
13
-
-
84903870684
-
Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease
-
Ayton S., Lei P., Adlard P. A., Volitakis I., Cherny R. A., Bush A. I. and Finkelstein D. I. (2014) Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease. Mol. Neurodegener. 9, 27.
-
(2014)
Mol. Neurodegener.
, vol.9
, pp. 27
-
-
Ayton, S.1
Lei, P.2
Adlard, P.A.3
Volitakis, I.4
Cherny, R.A.5
Bush, A.I.6
Finkelstein, D.I.7
-
14
-
-
84930225631
-
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE
-
Ayton S., Faux N. G. and Bush A. I. and Alzheimer's Disease Neuroimaging, I. (2015a) Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nat. Commun. 6, 6760.
-
(2015)
Nat. Commun.
, vol.6
, pp. 6760
-
-
Ayton, S.1
Faux, N.G.2
Bush, A.I.3
-
15
-
-
84926617255
-
Biometals and their therapeutic implications in Alzheimer's disease
-
Ayton S., Lei P. and Bush A. I. (2015b) Biometals and their therapeutic implications in Alzheimer's disease. Neurotherapeutics 12, 109–120.
-
(2015)
Neurotherapeutics
, vol.12
, pp. 109-120
-
-
Ayton, S.1
Lei, P.2
Bush, A.I.3
-
16
-
-
84923347844
-
Parkinson's disease iron deposition caused by nitric oxide-induced loss of beta-amyloid precursor protein
-
Ayton S., Lei P., Hare D. J. et al. (2015c) Parkinson's disease iron deposition caused by nitric oxide-induced loss of beta-amyloid precursor protein. J. Neurosci. 35, 3591–3597.
-
(2015)
J. Neurosci.
, vol.35
, pp. 3591-3597
-
-
Ayton, S.1
Lei, P.2
Hare, D.J.3
-
18
-
-
0005652488
-
MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease
-
Bartzokis G. and Tishler T. A. (2000) MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell. Mol. Biol. 46, 821–833.
-
(2000)
Cell. Mol. Biol.
, vol.46
, pp. 821-833
-
-
Bartzokis, G.1
Tishler, T.A.2
-
19
-
-
0028323318
-
In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI
-
Bartzokis G., Sultzer D., Mintz J., Holt L. E., Marx P., Phelan C. K. and Marder S. R. (1994) In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI. Biol. Psychiatry 35, 480–487.
-
(1994)
Biol. Psychiatry
, vol.35
, pp. 480-487
-
-
Bartzokis, G.1
Sultzer, D.2
Mintz, J.3
Holt, L.E.4
Marx, P.5
Phelan, C.K.6
Marder, S.R.7
-
20
-
-
34548790267
-
Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications
-
Bartzokis G., Lu P. H., Tishler T. A. et al. (2007) Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem. Res. 32, 1655–1664.
-
(2007)
Neurochem. Res.
, vol.32
, pp. 1655-1664
-
-
Bartzokis, G.1
Lu, P.H.2
Tishler, T.A.3
-
22
-
-
0035153971
-
Iron biology in immune function, muscle metabolism and neuronal functioning
-
discussion 580S
-
Beard J. L. (2001) Iron biology in immune function, muscle metabolism and neuronal functioning. J. Nutr. 131, 568S–579S; discussion 580S.
-
(2001)
J. Nutr.
, vol.131
, pp. 568S-579S
-
-
Beard, J.L.1
-
23
-
-
12244310166
-
Brain iron uptake in hypotransferrinemic mice: influence of systemic iron status
-
Beard J. L., Wiesinger J. A., Li N. and Connor J. R. (2005) Brain iron uptake in hypotransferrinemic mice: influence of systemic iron status. J. Neurosci. Res. 79, 254–261.
-
(2005)
J. Neurosci. Res.
, vol.79
, pp. 254-261
-
-
Beard, J.L.1
Wiesinger, J.A.2
Li, N.3
Connor, J.R.4
-
24
-
-
34247564692
-
Role of iron in neurodegenerative disorders
-
Berg D. and Youdim M. B. (2006) Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 17, 5–17.
-
(2006)
Top. Magn. Reson. Imaging
, vol.17
, pp. 5-17
-
-
Berg, D.1
Youdim, M.B.2
-
25
-
-
0033595447
-
Vulnerability of the nigrostriatal system as detected by transcranial ultrasound
-
Berg D., Becker G., Zeiler B. et al. (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53, 1026–1031.
-
(1999)
Neurology
, vol.53
, pp. 1026-1031
-
-
Berg, D.1
Becker, G.2
Zeiler, B.3
-
26
-
-
84857977037
-
Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms
-
von Bernhardi R. and Eugenin J. (2012) Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxid. Redox Signal. 16, 974–1031.
-
(2012)
Antioxid. Redox Signal.
, vol.16
, pp. 974-1031
-
-
von Bernhardi, R.1
Eugenin, J.2
-
27
-
-
0035126635
-
Heme oxygenase-1 (HSP-32) and heme oxygenase-2 induction in neurons and glial cells of cerebral regions and its relation to iron accumulation after focal cortical photothrombosis
-
Bidmon H. J., Emde B., Oermann E., Kubitz R., Witte O. W. and Zilles K. (2001) Heme oxygenase-1 (HSP-32) and heme oxygenase-2 induction in neurons and glial cells of cerebral regions and its relation to iron accumulation after focal cortical photothrombosis. Exp. Neurol. 168, 1–22.
-
(2001)
Exp. Neurol.
, vol.168
, pp. 1-22
-
-
Bidmon, H.J.1
Emde, B.2
Oermann, E.3
Kubitz, R.4
Witte, O.W.5
Zilles, K.6
-
28
-
-
84855461629
-
MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping
-
Bilgic B., Pfefferbaum A., Rohlfing T., Sullivan E. V. and Adalsteinsson E. (2012) MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. NeuroImage 59, 2625–2635.
-
(2012)
NeuroImage
, vol.59
, pp. 2625-2635
-
-
Bilgic, B.1
Pfefferbaum, A.2
Rohlfing, T.3
Sullivan, E.V.4
Adalsteinsson, E.5
-
29
-
-
34347370842
-
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
-
Boddaert N., Le Quan Sang K. H., Rotig A. et al. (2007) Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110, 401–408.
-
(2007)
Blood
, vol.110
, pp. 401-408
-
-
Boddaert, N.1
Le Quan Sang, K.H.2
Rotig, A.3
-
30
-
-
0028873173
-
Iron levels modulate alpha-secretase cleavage of amyloid precursor protein
-
Bodovitz S., Falduto M. T., Frail D. E. and Klein W. L. (1995) Iron levels modulate alpha-secretase cleavage of amyloid precursor protein. J. Neurochem. 64, 307–315.
-
(1995)
J. Neurochem.
, vol.64
, pp. 307-315
-
-
Bodovitz, S.1
Falduto, M.T.2
Frail, D.E.3
Klein, W.L.4
-
31
-
-
0033597299
-
Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease
-
Boll M. C., Sotelo J., Otero E., Alcaraz-Zubeldia M. and Rios C. (1999) Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease. Neurosci. Lett. 265, 155–158.
-
(1999)
Neurosci. Lett.
, vol.265
, pp. 155-158
-
-
Boll, M.C.1
Sotelo, J.2
Otero, E.3
Alcaraz-Zubeldia, M.4
Rios, C.5
-
32
-
-
0037428241
-
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
-
Bonifati V., Rizzu P., van Baren M. J. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256–259.
-
(2003)
Science
, vol.299
, pp. 256-259
-
-
Bonifati, V.1
Rizzu, P.2
van Baren, M.J.3
-
33
-
-
0030739637
-
Transport of iron in the blood-brain-cerebrospinal fluid system
-
Bradbury M. W. (1997) Transport of iron in the blood-brain-cerebrospinal fluid system. J. Neurochem. 69, 443–454.
-
(1997)
J. Neurochem.
, vol.69
, pp. 443-454
-
-
Bradbury, M.W.1
-
34
-
-
0033677772
-
The importance of non-transferrin bound iron in disorders of iron metabolism
-
Breuer W., Hershko C. and Cabantchik Z. I. (2000) The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus. Sci. 23, 185–192.
-
(2000)
Transfus. Sci.
, vol.23
, pp. 185-192
-
-
Breuer, W.1
Hershko, C.2
Cabantchik, Z.I.3
-
35
-
-
0035254193
-
Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy
-
Breuer W., Ermers M. J., Pootrakul P., Abramov A., Hershko C. and Cabantchik Z. I. (2001) Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. Blood 97, 792–798.
-
(2001)
Blood
, vol.97
, pp. 792-798
-
-
Breuer, W.1
Ermers, M.J.2
Pootrakul, P.3
Abramov, A.4
Hershko, C.5
Cabantchik, Z.I.6
-
37
-
-
84155180765
-
Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients
-
Breuer W., Ghoti H., Shattat A., Goldfarb A., Koren A., Levin C., Rachmilewitz E. and Cabantchik Z. I. (2012) Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients. Am. J. Hematol. 87, 55–61.
-
(2012)
Am. J. Hematol.
, vol.87
, pp. 55-61
-
-
Breuer, W.1
Ghoti, H.2
Shattat, A.3
Goldfarb, A.4
Koren, A.5
Levin, C.6
Rachmilewitz, E.7
Cabantchik, Z.I.8
-
38
-
-
0022345593
-
Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states
-
Brissot P., Wright T. L., Ma W. L. and Weisiger R. A. (1985) Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states. J. Clin. Invest. 76, 1463–1470.
-
(1985)
J. Clin. Invest.
, vol.76
, pp. 1463-1470
-
-
Brissot, P.1
Wright, T.L.2
Ma, W.L.3
Weisiger, R.A.4
-
39
-
-
84857373097
-
Non-transferrin bound iron: a key role in iron overload and iron toxicity
-
Brissot P., Ropert M., Le Lan C. and Loreal O. (2012) Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim. Biophys. Acta 1820, 403–410.
-
(2012)
Biochim. Biophys. Acta
, vol.1820
, pp. 403-410
-
-
Brissot, P.1
Ropert, M.2
Le Lan, C.3
Loreal, O.4
-
40
-
-
0035892632
-
Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat
-
Burdo J. R., Menzies S. L., Simpson I. A., Garrick L. M., Garrick M. D., Dolan K. G., Haile D. J., Beard J. L. and Connor J. R. (2001) Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66, 1198–1207.
-
(2001)
J. Neurosci. Res.
, vol.66
, pp. 1198-1207
-
-
Burdo, J.R.1
Menzies, S.L.2
Simpson, I.A.3
Garrick, L.M.4
Garrick, M.D.5
Dolan, K.G.6
Haile, D.J.7
Beard, J.L.8
Connor, J.R.9
-
41
-
-
0031793132
-
The significance of haemochromatosis gene mutations in the general population: implications for screening
-
Burt M. J., George P. M., Upton J. D., Collett J. A., Frampton C. M., Chapman T. M., Walmsley T. A. and Chapman B. A. (1998) The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43, 830–836.
-
(1998)
Gut
, vol.43
, pp. 830-836
-
-
Burt, M.J.1
George, P.M.2
Upton, J.D.3
Collett, J.A.4
Frampton, C.M.5
Chapman, T.M.6
Walmsley, T.A.7
Chapman, B.A.8
-
42
-
-
0037386086
-
The metallobiology of Alzheimer's disease
-
Bush A. I. (2003) The metallobiology of Alzheimer's disease. Trends Neurosci. 26, 207–214.
-
(2003)
Trends Neurosci.
, vol.26
, pp. 207-214
-
-
Bush, A.I.1
-
43
-
-
54249103057
-
Drug development based on the metals hypothesis of Alzheimer's disease
-
Bush A. I. (2008) Drug development based on the metals hypothesis of Alzheimer's disease. J. Alzheimers Dis. 15, 223–240.
-
(2008)
J. Alzheimers Dis.
, vol.15
, pp. 223-240
-
-
Bush, A.I.1
-
44
-
-
39749188801
-
Twenty years of metallo-neurobiology: where to now?
-
Bush A. I. and Curtain C. C. (2008) Twenty years of metallo-neurobiology: where to now? Eur. Biophys. J. 37, 241–245.
-
(2008)
Eur. Biophys. J.
, vol.37
, pp. 241-245
-
-
Bush, A.I.1
Curtain, C.C.2
-
45
-
-
84897930584
-
Labile iron in cells and body fluids: physiology, pathology, and pharmacology
-
Cabantchik Z. I. (2014) Labile iron in cells and body fluids: physiology, pathology, and pharmacology. Front. Pharmacol. 5, 45.
-
(2014)
Front. Pharmacol.
, vol.5
, pp. 45
-
-
Cabantchik, Z.I.1
-
46
-
-
38449094356
-
Iron-regulatory proteins: molecular biology and pathophysiological implications
-
Cairo G. and Recalcati S. (2007) Iron-regulatory proteins: molecular biology and pathophysiological implications. Expert Rev. Mol. Med. 9, 1–13.
-
(2007)
Expert Rev. Mol. Med.
, vol.9
, pp. 1-13
-
-
Cairo, G.1
Recalcati, S.2
-
47
-
-
84879845983
-
Roles of the amyloid precursor protein family in the peripheral nervous system
-
Caldwell J. H., Klevanski M., Saar M. and Muller U. C. (2013) Roles of the amyloid precursor protein family in the peripheral nervous system. Mech. Dev. 130, 433–446.
-
(2013)
Mech. Dev.
, vol.130
, pp. 433-446
-
-
Caldwell, J.H.1
Klevanski, M.2
Saar, M.3
Muller, U.C.4
-
48
-
-
84899898647
-
Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging
-
Callaghan M. F., Freund P., Draganski B. et al. (2014) Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging. Neurobiol. Aging 35, 1862–1872.
-
(2014)
Neurobiol. Aging
, vol.35
, pp. 1862-1872
-
-
Callaghan, M.F.1
Freund, P.2
Draganski, B.3
-
49
-
-
0242500486
-
Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy
-
Candore G., Licastro F., Chiappelli M. et al. (2003) Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy. Mech. Ageing Dev. 124, 525–528.
-
(2003)
Mech. Ageing Dev.
, vol.124
, pp. 525-528
-
-
Candore, G.1
Licastro, F.2
Chiappelli, M.3
-
51
-
-
33747429095
-
Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency
-
Chan A. and Shea T. B. (2006) Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency. J. Alzheimers Dis. 9, 399–405.
-
(2006)
J. Alzheimers Dis.
, vol.9
, pp. 399-405
-
-
Chan, A.1
Shea, T.B.2
-
52
-
-
0035911810
-
Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains
-
Cheepsunthorn P., Palmer C., Menzies S., Roberts R. L. and Connor J. R. (2001) Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains. J. Comp. Neurol. 431, 382–396.
-
(2001)
J. Comp. Neurol.
, vol.431
, pp. 382-396
-
-
Cheepsunthorn, P.1
Palmer, C.2
Menzies, S.3
Roberts, R.L.4
Connor, J.R.5
-
53
-
-
84885404060
-
Iron Accumulates in Huntington's Disease Neurons: protection by Deferoxamine
-
Chen J. F., Marks E., Lai B. et al. (2013) Iron Accumulates in Huntington's Disease Neurons: protection by Deferoxamine. PLoS ONE, 8, e77023.
-
(2013)
PLoS ONE
, vol.8
-
-
Chen, J.F.1
Marks, E.2
Lai, B.3
-
54
-
-
0034964390
-
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice
-
Cherny R. A., Atwood C. S., Xilinas M. E. et al. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665–676.
-
(2001)
Neuron
, vol.30
, pp. 665-676
-
-
Cherny, R.A.1
Atwood, C.S.2
Xilinas, M.E.3
-
55
-
-
84885372632
-
PBT2 Reduces Toxicity in a C. elegans Model of polyQ Aggregation and Extends Lifespan, Reduces Striatal Atrophy and Improves Motor Performance in the R6/2 Mouse Model of Huntington's Disease
-
Cherny R. A., Ayton S., Finkelstein D. I., Bush A. I., McColl G. and Massa S. M. (2012) PBT2 Reduces Toxicity in a C. elegans Model of polyQ Aggregation and Extends Lifespan, Reduces Striatal Atrophy and Improves Motor Performance in the R6/2 Mouse Model of Huntington's Disease. J. Huntingtons Dis. 1, 211–219.
-
(2012)
J. Huntingtons Dis.
, vol.1
, pp. 211-219
-
-
Cherny, R.A.1
Ayton, S.2
Finkelstein, D.I.3
Bush, A.I.4
McColl, G.5
Massa, S.M.6
-
56
-
-
84875449765
-
Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease
-
Chetelat G., La Joie R., Villain N., Perrotin A., de La Sayette V., Eustache F. and Vandenberghe R. (2013) Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease. Neuroimage Clin. 2, 356–365.
-
(2013)
Neuroimage Clin.
, vol.2
, pp. 356-365
-
-
Chetelat, G.1
La Joie, R.2
Villain, N.3
Perrotin, A.4
de La Sayette, V.5
Eustache, F.6
Vandenberghe, R.7
-
57
-
-
12244274984
-
Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease
-
Combarros O., Garcia-Roman M., Fontalba A., Fernandez-Luna J. L., Llorca J., Infante J. and Berciano J. (2003) Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 15, 151–154.
-
(2003)
Dement. Geriatr. Cogn. Disord.
, vol.15
, pp. 151-154
-
-
Combarros, O.1
Garcia-Roman, M.2
Fontalba, A.3
Fernandez-Luna, J.L.4
Llorca, J.5
Infante, J.6
Berciano, J.7
-
58
-
-
0030174825
-
Relationship of iron to oligodendrocytes and myelination
-
Connor J. R. and Menzies S. L. (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17, 83–93.
-
(1996)
Glia
, vol.17
, pp. 83-93
-
-
Connor, J.R.1
Menzies, S.L.2
-
59
-
-
0025648166
-
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains
-
Connor J. R., Menzies S. L., St Martin S. M. and Mufson E. J. (1990) Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J. Neurosci. Res. 27, 595–611.
-
(1990)
J. Neurosci. Res.
, vol.27
, pp. 595-611
-
-
Connor, J.R.1
Menzies, S.L.2
St Martin, S.M.3
Mufson, E.J.4
-
60
-
-
0026513756
-
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains
-
Connor J. R., Menzies S. L., St Martin S. M. and Mufson E. J. (1992a) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 31, 75–83.
-
(1992)
J. Neurosci. Res.
, vol.31
, pp. 75-83
-
-
Connor, J.R.1
Menzies, S.L.2
St Martin, S.M.3
Mufson, E.J.4
-
61
-
-
0026590705
-
Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease
-
Connor J. R., Snyder B. S., Beard J. L., Fine R. E. and Mufson E. J. (1992b) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J. Neurosci. Res. 31, 327–335.
-
(1992)
J. Neurosci. Res.
, vol.31
, pp. 327-335
-
-
Connor, J.R.1
Snyder, B.S.2
Beard, J.L.3
Fine, R.E.4
Mufson, E.J.5
-
63
-
-
0029024235
-
A histochemical study of iron-positive cells in the developing rat brain
-
Connor J. R., Pavlick G., Karli D., Menzies S. L. and Palmer C. (1995a) A histochemical study of iron-positive cells in the developing rat brain. J. Comp. Neurol. 355, 111–123.
-
(1995)
J. Comp. Neurol.
, vol.355
, pp. 111-123
-
-
Connor, J.R.1
Pavlick, G.2
Karli, D.3
Menzies, S.L.4
Palmer, C.5
-
64
-
-
0029092802
-
A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains
-
Connor J. R., Snyder B. S., Arosio P., Loeffler D. A. and LeWitt P. (1995b) A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J. Neurochem. 65, 717–724.
-
(1995)
J. Neurochem.
, vol.65
, pp. 717-724
-
-
Connor, J.R.1
Snyder, B.S.2
Arosio, P.3
Loeffler, D.A.4
LeWitt, P.5
-
65
-
-
0027194791
-
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
-
Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L. and Pericak-Vance M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921–923.
-
(1993)
Science
, vol.261
, pp. 921-923
-
-
Corder, E.H.1
Saunders, A.M.2
Strittmatter, W.J.3
Schmechel, D.E.4
Gaskell, P.C.5
Small, G.W.6
Roses, A.D.7
Haines, J.L.8
Pericak-Vance, M.A.9
-
66
-
-
33747154110
-
Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder
-
Cozzi A., Santambrogio P., Corsi B., Campanella A., Arosio P. and Levi S. (2006) Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder. Neurobiol. Dis. 23, 644–652.
-
(2006)
Neurobiol. Dis.
, vol.23
, pp. 644-652
-
-
Cozzi, A.1
Santambrogio, P.2
Corsi, B.3
Campanella, A.4
Arosio, P.5
Levi, S.6
-
67
-
-
0025726462
-
Intramuscular desferrioxamine in patients with Alzheimer's disease
-
Crapper McLachlan D. R., Dalton A. J., Kruck T. P., Bell M. Y., Smith W. L., Kalow W. and Andrews D. F. (1991) Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337, 1304–1308.
-
(1991)
Lancet
, vol.337
, pp. 1304-1308
-
-
Crapper McLachlan, D.R.1
Dalton, A.J.2
Kruck, T.P.3
Bell, M.Y.4
Smith, W.L.5
Kalow, W.6
Andrews, D.F.7
-
68
-
-
0026472376
-
Iron metabolism–new perspectives in view
-
Crichton R. R. and Ward R. J. (1992) Iron metabolism–new perspectives in view. Biochemistry 31, 11255–11264.
-
(1992)
Biochemistry
, vol.31
, pp. 11255-11264
-
-
Crichton, R.R.1
Ward, R.J.2
-
69
-
-
80052684579
-
The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity
-
Crouch P. J., Savva M. S., Hung L. W. et al. (2011) The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity. J. Neurochem. 119, 220–230.
-
(2011)
J. Neurochem.
, vol.119
, pp. 220-230
-
-
Crouch, P.J.1
Savva, M.S.2
Hung, L.W.3
-
70
-
-
0026779690
-
Iron and transferrin uptake by brain and cerebrospinal fluid in the rat
-
Crowe A. and Morgan E. H. (1992) Iron and transferrin uptake by brain and cerebrospinal fluid in the rat. Brain Res. 592, 8–16.
-
(1992)
Brain Res.
, vol.592
, pp. 8-16
-
-
Crowe, A.1
Morgan, E.H.2
-
71
-
-
80052689794
-
Hepcidin and ferroportin: the new players in iron metabolism
-
De Domenico I., Ward D. M. and Kaplan J. (2011) Hepcidin and ferroportin: the new players in iron metabolism. Semin. Liver Dis. 31, 272–279.
-
(2011)
Semin. Liver Dis.
, vol.31
, pp. 272-279
-
-
De Domenico, I.1
Ward, D.M.2
Kaplan, J.3
-
72
-
-
1042301280
-
Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain
-
Deane R., Zheng W. and Zlokovic B. V. (2004) Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain. J. Neurochem. 88, 813–820.
-
(2004)
J. Neurochem.
, vol.88
, pp. 813-820
-
-
Deane, R.1
Zheng, W.2
Zlokovic, B.V.3
-
73
-
-
84856570373
-
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons
-
Decressac M., Mattsson B., Lundblad M., Weikop P. and Bjorklund A. (2012) Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons. Neurobiol. Dis. 45, 939–953.
-
(2012)
Neurobiol. Dis.
, vol.45
, pp. 939-953
-
-
Decressac, M.1
Mattsson, B.2
Lundblad, M.3
Weikop, P.4
Bjorklund, A.5
-
74
-
-
84897930725
-
Targeting chelatable iron as a therapeutic modality in Parkinson's disease
-
Devos D., Moreau C., Devedjian J. C. et al. (2014) Targeting chelatable iron as a therapeutic modality in Parkinson's disease. Antioxid. Redox Signal. 21, 195–210.
-
(2014)
Antioxid. Redox Signal.
, vol.21
, pp. 195-210
-
-
Devos, D.1
Moreau, C.2
Devedjian, J.C.3
-
75
-
-
0023638828
-
Increased nigral iron content in postmortem parkinsonian brain
-
Dexter D. T., Wells F. R., Agid F., Agid Y., Lees A. J., Jenner P. and Marsden C. D. (1987) Increased nigral iron content in postmortem parkinsonian brain. Lancet 2, 1219–1220.
-
(1987)
Lancet
, vol.2
, pp. 1219-1220
-
-
Dexter, D.T.1
Wells, F.R.2
Agid, F.3
Agid, Y.4
Lees, A.J.5
Jenner, P.6
Marsden, C.D.7
-
76
-
-
0024356620
-
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease
-
Dexter D. T., Wells F. R., Lees A. J., Agid F., Agid Y., Jenner P. and Marsden C. D. (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52, 1830–1836.
-
(1989)
J. Neurochem.
, vol.52
, pp. 1830-1836
-
-
Dexter, D.T.1
Wells, F.R.2
Lees, A.J.3
Agid, F.4
Agid, Y.5
Jenner, P.6
Marsden, C.D.7
-
77
-
-
0025821265
-
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia
-
Dexter D. T., Carayon A., Javoy-Agid F., Agid Y., Wells F. R., Daniel S. E., Lees A. J., Jenner P. and Marsden C. D. (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt 4), 1953–1975.
-
(1991)
Brain
, vol.114
, pp. 1953-1975
-
-
Dexter, D.T.1
Carayon, A.2
Javoy-Agid, F.3
Agid, Y.4
Wells, F.R.5
Daniel, S.E.6
Lees, A.J.7
Jenner, P.8
Marsden, C.D.9
-
78
-
-
65249141710
-
Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease
-
Ding B., Chen K. M., Ling H. W. et al. (2009) Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease. J. Magn. Reson. Imaging 29, 793–798.
-
(2009)
J. Magn. Reson. Imaging
, vol.29
, pp. 793-798
-
-
Ding, B.1
Chen, K.M.2
Ling, H.W.3
-
79
-
-
84890922670
-
The role of iron and reactive oxygen species in cell death
-
Dixon S. J. and Stockwell B. R. (2014) The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9–17.
-
(2014)
Nat. Chem. Biol.
, vol.10
, pp. 9-17
-
-
Dixon, S.J.1
Stockwell, B.R.2
-
80
-
-
84861541814
-
Ferroptosis: an iron-dependent form of nonapoptotic cell death
-
Dixon S. J., Lemberg K. M., Lamprecht M. R. et al. (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072.
-
(2012)
Cell
, vol.149
, pp. 1060-1072
-
-
Dixon, S.J.1
Lemberg, K.M.2
Lamprecht, M.R.3
-
81
-
-
20444416123
-
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
-
Donovan A., Lima C. A., Pinkus J. L., Pinkus G. S., Zon L. I., Robine S. and Andrews N. C. (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1, 191–200.
-
(2005)
Cell Metab.
, vol.1
, pp. 191-200
-
-
Donovan, A.1
Lima, C.A.2
Pinkus, J.L.3
Pinkus, G.S.4
Zon, L.I.5
Robine, S.6
Andrews, N.C.7
-
82
-
-
0022529733
-
MRI of brain iron
-
Drayer B., Burger P., Darwin R., Riederer S., Herfkens R. and Johnson G. A. (1986) MRI of brain iron. AJR Am. J. Roentgenol. 147, 103–110.
-
(1986)
AJR Am. J. Roentgenol.
, vol.147
, pp. 103-110
-
-
Drayer, B.1
Burger, P.2
Darwin, R.3
Riederer, S.4
Herfkens, R.5
Johnson, G.A.6
-
83
-
-
77956647381
-
Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease
-
Duce J. A., Tsatsanis A., Cater M. A. et al. (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857–867.
-
(2010)
Cell
, vol.142
, pp. 857-867
-
-
Duce, J.A.1
Tsatsanis, A.2
Cater, M.A.3
-
84
-
-
33749506795
-
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
-
Engler H., Forsberg A., Almkvist O. et al. (2006) Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 129, 2856–2866.
-
(2006)
Brain
, vol.129
, pp. 2856-2866
-
-
Engler, H.1
Forsberg, A.2
Almkvist, O.3
-
85
-
-
0028174370
-
The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis
-
Enochs W. S., Sarna T., Zecca L., Riley P. A. and Swartz H. M. (1994) The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis. J. Neural. Transm. Park. Dis. Dement. Sect. 7, 83–100.
-
(1994)
J. Neural. Transm. Park. Dis. Dement. Sect.
, vol.7
, pp. 83-100
-
-
Enochs, W.S.1
Sarna, T.2
Zecca, L.3
Riley, P.A.4
Swartz, H.M.5
-
86
-
-
0027358656
-
Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA
-
Fahmy M. and Young S. P. (1993) Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem. J. 296(Pt 1), 175–181.
-
(1993)
Biochem. J.
, vol.296
, pp. 175-181
-
-
Fahmy, M.1
Young, S.P.2
-
87
-
-
0036798434
-
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease
-
Faucheux B. A., Martin M. E., Beaumont C., Hunot S., Hauw J. J., Agid Y. and Hirsch E. C. (2002) Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. J. Neurochem. 83, 320–330.
-
(2002)
J. Neurochem.
, vol.83
, pp. 320-330
-
-
Faucheux, B.A.1
Martin, M.E.2
Beaumont, C.3
Hunot, S.4
Hauw, J.J.5
Agid, Y.6
Hirsch, E.C.7
-
88
-
-
84908897414
-
An anemia of Alzheimer's disease
-
Faux N. G., Rembach A., Wiley J. et al. (2014) An anemia of Alzheimer's disease. Mol. Psychiatry 19, 1227–1234.
-
(2014)
Mol. Psychiatry
, vol.19
, pp. 1227-1234
-
-
Faux, N.G.1
Rembach, A.2
Wiley, J.3
-
89
-
-
0025954066
-
Ageing and Parkinson's disease: substantia nigra regional selectivity
-
Fearnley J. M. and Lees A. J. (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114(Pt 5), 2283–2301.
-
(1991)
Brain
, vol.114
, pp. 2283-2301
-
-
Fearnley, J.M.1
Lees, A.J.2
-
90
-
-
84876976065
-
Chronic intranasal deferoxamine ameliorates motor defects and pathology in the alpha-synuclein rAAV Parkinson's model
-
Febbraro F., Andersen K. J., Sanchez-Guajardo V., Tentillier N. and Romero-Ramos M. (2013) Chronic intranasal deferoxamine ameliorates motor defects and pathology in the alpha-synuclein rAAV Parkinson's model. Exp. Neurol. 247, 45–58.
-
(2013)
Exp. Neurol.
, vol.247
, pp. 45-58
-
-
Febbraro, F.1
Andersen, K.J.2
Sanchez-Guajardo, V.3
Tentillier, N.4
Romero-Ramos, M.5
-
91
-
-
84874768493
-
Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice
-
Fine J. M., Baillargeon A. M., Renner D. B. et al. (2012) Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice. Exp. Brain Res. 219, 381–390.
-
(2012)
Exp. Brain Res.
, vol.219
, pp. 381-390
-
-
Fine, J.M.1
Baillargeon, A.M.2
Renner, D.B.3
-
92
-
-
84925286831
-
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
-
Friedmann Angeli J. P., Schneider M., Proneth B. et al. (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180–1191.
-
(2014)
Nat. Cell Biol.
, vol.16
, pp. 1180-1191
-
-
Friedmann Angeli, J.P.1
Schneider, M.2
Proneth, B.3
-
93
-
-
84939986310
-
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
-
Galluzzi L., Bravo-San Pedro J. M., Vitale I. et al. (2015) Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 22, 58–73.
-
(2015)
Cell Death Differ.
, vol.22
, pp. 58-73
-
-
Galluzzi, L.1
Bravo-San Pedro, J.M.2
Vitale, I.3
-
94
-
-
0028000825
-
Altered brain metabolism of iron as a cause of neurodegenerative diseases?
-
Gerlach M., Ben-Shachar D., Riederer P. and Youdim M. B. (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63, 793–807.
-
(1994)
J. Neurochem.
, vol.63
, pp. 793-807
-
-
Gerlach, M.1
Ben-Shachar, D.2
Riederer, P.3
Youdim, M.B.4
-
95
-
-
84922814574
-
R2* mapping for brain iron: associations with cognition in normal aging
-
Ghadery C., Pirpamer L., Hofer E. et al. (2014) R2* mapping for brain iron: associations with cognition in normal aging. Neurobiol. Aging, 36, 925–932.
-
(2014)
Neurobiol. Aging
, vol.36
, pp. 925-932
-
-
Ghadery, C.1
Pirpamer, L.2
Hofer, E.3
-
96
-
-
50149099153
-
Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice
-
Ghosh M. C., Tong W. H., Zhang D., Ollivierre-Wilson H., Singh A., Krishna M. C., Mitchell J. B. and Rouault T. A. (2008) Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice. Proc. Natl Acad. Sci. USA 105, 12028–12033.
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, pp. 12028-12033
-
-
Ghosh, M.C.1
Tong, W.H.2
Zhang, D.3
Ollivierre-Wilson, H.4
Singh, A.5
Krishna, M.C.6
Mitchell, J.B.7
Rouault, T.A.8
-
97
-
-
84873338684
-
Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2alpha
-
Ghosh M. C., Zhang D. L., Jeong S. Y. et al. (2013) Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2alpha. Cell Metab. 17, 271–281.
-
(2013)
Cell Metab.
, vol.17
, pp. 271-281
-
-
Ghosh, M.C.1
Zhang, D.L.2
Jeong, S.Y.3
-
98
-
-
84938039523
-
Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis
-
Goodman L. (1953) Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J. Nerv. Ment. Dis. 118, 97–130.
-
(1953)
J. Nerv. Ment. Dis.
, vol.118
, pp. 97-130
-
-
Goodman, L.1
-
99
-
-
84875697145
-
Metal dyshomeostasis and oxidative stress in Alzheimer's disease
-
Greenough M. A., Camakaris J. and Bush A. I. (2013) Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem. Int. 62, 540–555.
-
(2013)
Neurochem. Int.
, vol.62
, pp. 540-555
-
-
Greenough, M.A.1
Camakaris, J.2
Bush, A.I.3
-
100
-
-
0027193251
-
Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease
-
Griffiths P. D. and Crossman A. R. (1993) Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. Dementia 4, 61–65.
-
(1993)
Dementia
, vol.4
, pp. 61-65
-
-
Griffiths, P.D.1
Crossman, A.R.2
-
101
-
-
0032898122
-
Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy
-
Griffiths P. D., Dobson B. R., Jones G. R. and Clarke D. T. (1999) Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain, 122 (Pt 4), 667–673.
-
(1999)
Brain
, vol.122
, pp. 667-673
-
-
Griffiths, P.D.1
Dobson, B.R.2
Jones, G.R.3
Clarke, D.T.4
-
102
-
-
67849106894
-
Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease
-
Grossi C., Francese S., Casini A. et al. (2009) Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. J. Alzheimers Dis. 17, 423–440.
-
(2009)
J. Alzheimers Dis.
, vol.17
, pp. 423-440
-
-
Grossi, C.1
Francese, S.2
Casini, A.3
-
103
-
-
33747179546
-
Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort
-
Guerreiro R. J., Bras J. M., Santana I. et al. (2006) Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort. BMC Neurol. 6, 24.
-
(2006)
BMC Neurol.
, vol.6
, pp. 24
-
-
Guerreiro, R.J.1
Bras, J.M.2
Santana, I.3
-
104
-
-
84938261417
-
Decrease in APP and CP mRNA expression supports impairment of iron export in Alzheimer's disease patients
-
Guerreiro C., Silva B., Crespo A. C. et al. (2015) Decrease in APP and CP mRNA expression supports impairment of iron export in Alzheimer's disease patients. Biochim. Biophys. Acta, 1852, 2116–2122.
-
(2015)
Biochim. Biophys. Acta
, vol.1852
, pp. 2116-2122
-
-
Guerreiro, C.1
Silva, B.2
Crespo, A.C.3
-
105
-
-
84869080922
-
Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease
-
Guo C., Wang T., Zheng W., Shan Z. Y., Teng W. P. and Wang Z. Y. (2013) Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 34, 562–575.
-
(2013)
Neurobiol. Aging
, vol.34
, pp. 562-575
-
-
Guo, C.1
Wang, T.2
Zheng, W.3
Shan, Z.Y.4
Teng, W.P.5
Wang, Z.Y.6
-
106
-
-
84936118142
-
Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1alpha pathway on the brain of APP/PS1 transgenic mice
-
Guo C., Zhang Y. X., Wang T., Zhong M. L., Yang Z. H., Hao L. J., Chai R. and Zhang S. (2015) Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1alpha pathway on the brain of APP/PS1 transgenic mice. Front. Aging Neurosci. 7, 104.
-
(2015)
Front. Aging Neurosci.
, vol.7
, pp. 104
-
-
Guo, C.1
Zhang, Y.X.2
Wang, T.3
Zhong, M.L.4
Yang, Z.H.5
Hao, L.J.6
Chai, R.7
Zhang, S.8
-
107
-
-
13944261999
-
Imaging iron stores in the brain using magnetic resonance imaging
-
Haacke E. M., Cheng N. Y., House M. J. et al. (2005) Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 23, 1–25.
-
(2005)
Magn. Reson. Imaging
, vol.23
, pp. 1-25
-
-
Haacke, E.M.1
Cheng, N.Y.2
House, M.J.3
-
108
-
-
0037309720
-
Gene expression of transferrin and transferrin receptor in brains of control vs. iron-deficient rats
-
Han J., Day J. R., Connor J. R. and Beard J. L. (2003) Gene expression of transferrin and transferrin receptor in brains of control vs. iron-deficient rats. Nutr. Neurosci. 6, 1–10.
-
(2003)
Nutr. Neurosci.
, vol.6
, pp. 1-10
-
-
Han, J.1
Day, J.R.2
Connor, J.R.3
Beard, J.L.4
-
109
-
-
84897365963
-
A delicate balance: iron metabolism and diseases of the brain
-
Hare D., Ayton S., Bush A. and Lei P. (2013a) A delicate balance: iron metabolism and diseases of the brain. Front. Aging Neurosci. 5, 34.
-
(2013)
Front. Aging Neurosci.
, vol.5
, pp. 34
-
-
Hare, D.1
Ayton, S.2
Bush, A.3
Lei, P.4
-
110
-
-
84888192566
-
Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry
-
Hare D. J., Grubman A., Ryan T. M. et al. (2013b) Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry. Metallomics, 5, 1656–1662.
-
(2013)
Metallomics
, vol.5
, pp. 1656-1662
-
-
Hare, D.J.1
Grubman, A.2
Ryan, T.M.3
-
111
-
-
84900302515
-
An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta
-
Hare D. J., Lei P., Ayton S. et al. (2014) An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta. Chem. Sci. 5, 2160–2169.
-
(2014)
Chem. Sci.
, vol.5
, pp. 2160-2169
-
-
Hare, D.J.1
Lei, P.2
Ayton, S.3
-
112
-
-
84941022712
-
Is early-life iron exposure critical in neurodegeneration?
-
Hare D. J., Arora M., Jenkins N. L., Finkelstein D. I., Doble P. A. and Bush A. I. (2015a) Is early-life iron exposure critical in neurodegeneration? Nat. Rev. Neurol. 11, 536–544.
-
(2015)
Nat. Rev. Neurol.
, vol.11
, pp. 536-544
-
-
Hare, D.J.1
Arora, M.2
Jenkins, N.L.3
Finkelstein, D.I.4
Doble, P.A.5
Bush, A.I.6
-
113
-
-
84925682121
-
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation
-
Hare D. J., Doecke J. D., Faux N. G. et al. (2015b) Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation. ACS Chem. Neurosci. 6, 398–402.
-
(2015)
ACS Chem. Neurosci.
, vol.6
, pp. 398-402
-
-
Hare, D.J.1
Doecke, J.D.2
Faux, N.G.3
-
114
-
-
0000819723
-
Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution
-
Hill J. M., Ruff M. R., Weber R. J. and Pert C. B. (1985) Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. Proc. Natl Acad. Sci. USA 82, 4553–4557.
-
(1985)
Proc. Natl Acad. Sci. USA
, vol.82
, pp. 4553-4557
-
-
Hill, J.M.1
Ruff, M.R.2
Weber, R.J.3
Pert, C.B.4
-
115
-
-
27244457379
-
DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression
-
Hintze K. J. and Theil E. C. (2005) DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression. Proc. Natl Acad. Sci. USA 102, 15048–15052.
-
(2005)
Proc. Natl Acad. Sci. USA
, vol.102
, pp. 15048-15052
-
-
Hintze, K.J.1
Theil, E.C.2
-
116
-
-
0026034279
-
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis
-
Hirsch E. C., Brandel J. P., Galle P., Javoy-Agid F. and Agid Y. (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem. 56, 446–451.
-
(1991)
J. Neurochem.
, vol.56
, pp. 446-451
-
-
Hirsch, E.C.1
Brandel, J.P.2
Galle, P.3
Javoy-Agid, F.4
Agid, Y.5
-
117
-
-
84909578703
-
Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
-
Huang Y. and Mahley R. W. (2014) Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol. Dis., 72PA, 3–12.
-
(2014)
Neurobiol. Dis.
, vol.72PA
, pp. 3-12
-
-
Huang, Y.1
Mahley, R.W.2
-
118
-
-
0033601338
-
Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction
-
Huang X., Cuajungco M. P., Atwood C. S. et al. (1999) Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 274, 37111–37116.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 37111-37116
-
-
Huang, X.1
Cuajungco, M.P.2
Atwood, C.S.3
-
119
-
-
12144282992
-
Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides
-
Huang X., Atwood C. S., Moir R. D., Hartshorn M. A., Tanzi R. E. and Bush A. I. (2004) Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J. Biol. Inorg. Chem. 9, 954–960.
-
(2004)
J. Biol. Inorg. Chem.
, vol.9
, pp. 954-960
-
-
Huang, X.1
Atwood, C.S.2
Moir, R.D.3
Hartshorn, M.A.4
Tanzi, R.E.5
Bush, A.I.6
-
120
-
-
0032956629
-
Characterization and distribution of ferritin binding sites in the adult mouse brain
-
Hulet S. W., Hess E. J., Debinski W., Arosio P., Bruce K., Powers S. and Connor J. R. (1999) Characterization and distribution of ferritin binding sites in the adult mouse brain. J. Neurochem. 72, 868–874.
-
(1999)
J. Neurochem.
, vol.72
, pp. 868-874
-
-
Hulet, S.W.1
Hess, E.J.2
Debinski, W.3
Arosio, P.4
Bruce, K.5
Powers, S.6
Connor, J.R.7
-
121
-
-
84926387317
-
Ferroptosis as a p53-mediated activity during tumour suppression
-
Jiang L., Kon N., Li T., Wang S. J., Su T., Hibshoosh H., Baer R. and Gu W. (2015) Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57–62.
-
(2015)
Nature
, vol.520
, pp. 57-62
-
-
Jiang, L.1
Kon, N.2
Li, T.3
Wang, S.J.4
Su, T.5
Hibshoosh, H.6
Baer, R.7
Gu, W.8
-
122
-
-
78449282609
-
Metals, oxidative stress and neurodegenerative disorders
-
Jomova K., Vondrakova D., Lawson M. and Valko M. (2010) Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 345, 91–104.
-
(2010)
Mol. Cell. Biochem.
, vol.345
, pp. 91-104
-
-
Jomova, K.1
Vondrakova, D.2
Lawson, M.3
Valko, M.4
-
123
-
-
0242684415
-
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease
-
Kaur D., Yantiri F., Rajagopalan S. et al. (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37, 899–909.
-
(2003)
Neuron
, vol.37
, pp. 899-909
-
-
Kaur, D.1
Yantiri, F.2
Rajagopalan, S.3
-
124
-
-
0032499264
-
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
-
Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y. and Shimizu N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605–608.
-
(1998)
Nature
, vol.392
, pp. 605-608
-
-
Kitada, T.1
Asakawa, S.2
Hattori, N.3
Matsumine, H.4
Yamamura, Y.5
Minoshima, S.6
Yokochi, M.7
Mizuno, Y.8
Shimizu, N.9
-
125
-
-
85047682134
-
Steap proteins: implications for iron and copper metabolism
-
Knutson M. D. (2007) Steap proteins: implications for iron and copper metabolism. Nutr. Rev. 65, 335–340.
-
(2007)
Nutr. Rev.
, vol.65
, pp. 335-340
-
-
Knutson, M.D.1
-
127
-
-
79954460490
-
Childhood disorders of neurodegeneration with brain iron accumulation (NBIA)
-
Kurian M. A., McNeill A., Lin J. P. and Maher E. R. (2011) Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev. Med. Child Neurol. 53, 394–404.
-
(2011)
Dev. Med. Child Neurol.
, vol.53
, pp. 394-404
-
-
Kurian, M.A.1
McNeill, A.2
Lin, J.P.3
Maher, E.R.4
-
128
-
-
84655167560
-
Long-term improvement under deferiprone in a case of neurodegeneration with brain iron accumulation
-
Kwiatkowski A., Ryckewaert G., Jissendi Tchofo P., Moreau C., Vuillaume I., Chinnery P. F., Destee A., Defebvre L. and Devos D. (2012) Long-term improvement under deferiprone in a case of neurodegeneration with brain iron accumulation. Parkinsonism Relat. Disord. 18, 110–112.
-
(2012)
Parkinsonism Relat. Disord.
, vol.18
, pp. 110-112
-
-
Kwiatkowski, A.1
Ryckewaert, G.2
Jissendi Tchofo, P.3
Moreau, C.4
Vuillaume, I.5
Chinnery, P.F.6
Destee, A.7
Defebvre, L.8
Devos, D.9
-
129
-
-
84896690191
-
MRI for iron mapping in Alzheimer's disease
-
Langkammer C., Ropele S., Pirpamer L., Fazekas F. and Schmidt R. (2014) MRI for iron mapping in Alzheimer's disease. Neurodegener. Dis. 13, 189–191.
-
(2014)
Neurodegener. Dis.
, vol.13
, pp. 189-191
-
-
Langkammer, C.1
Ropele, S.2
Pirpamer, L.3
Fazekas, F.4
Schmidt, R.5
-
130
-
-
0035138456
-
Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice
-
LaVaute T., Smith S., Cooperman S. et al. (2001) Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27, 209–214.
-
(2001)
Nat. Genet.
, vol.27
, pp. 209-214
-
-
LaVaute, T.1
Smith, S.2
Cooperman, S.3
-
131
-
-
77957260958
-
Tau protein: relevance to Parkinson's disease
-
Lei P., Ayton S., Finkelstein D. I., Adlard P. A., Masters C. L. and Bush A. I. (2010) Tau protein: relevance to Parkinson's disease. Int. J. Biochem. Cell B 42, 1775–1778.
-
(2010)
Int. J. Biochem. Cell B
, vol.42
, pp. 1775-1778
-
-
Lei, P.1
Ayton, S.2
Finkelstein, D.I.3
Adlard, P.A.4
Masters, C.L.5
Bush, A.I.6
-
132
-
-
84856708923
-
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
-
Lei P., Ayton S., Finkelstein D. I. et al. (2012) Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat. Med. 18, 291–295.
-
(2012)
Nat. Med.
, vol.18
, pp. 291-295
-
-
Lei, P.1
Ayton, S.2
Finkelstein, D.I.3
-
133
-
-
84906922815
-
Motor and cognitive deficits in aged tau knockout mice in two background strains
-
Lei P., Ayton S., Moon S., Zhang Q., Volitakis I., Finkelstein D. I. and Bush A. I. (2014) Motor and cognitive deficits in aged tau knockout mice in two background strains. Mol. Neurodegener. 9, 29.
-
(2014)
Mol. Neurodegener.
, vol.9
, pp. 29
-
-
Lei, P.1
Ayton, S.2
Moon, S.3
Zhang, Q.4
Volitakis, I.5
Finkelstein, D.I.6
Bush, A.I.7
-
134
-
-
84936987315
-
Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse
-
Lei P., Ayton S., Appukuttan A. T., Volitakis I., Adlard P. A., Finkelstein D. I. and Bush A. I. (2015) Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse. Neurobiol. Dis. 81, 168–175.
-
(2015)
Neurobiol. Dis.
, vol.81
, pp. 168-175
-
-
Lei, P.1
Ayton, S.2
Appukuttan, A.T.3
Volitakis, I.4
Adlard, P.A.5
Finkelstein, D.I.6
Bush, A.I.7
-
135
-
-
84906417439
-
Original papers: on the occurrence of abnormal deposits of iron in the brain in parkinsonism with special reference to its localisation
-
Lhermitte J., Kraus W. M. and McAlpine D. (1924) Original papers: on the occurrence of abnormal deposits of iron in the brain in parkinsonism with special reference to its localisation. J. Neurol. Psychopathol. 5, 195–208.
-
(1924)
J. Neurol. Psychopathol.
, vol.5
, pp. 195-208
-
-
Lhermitte, J.1
Kraus, W.M.2
McAlpine, D.3
-
136
-
-
77649268711
-
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1
-
Li L., Fang C. J., Ryan J. C. et al. (2010) Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc. Natl Acad. Sci. USA 107, 3505–3510.
-
(2010)
Proc. Natl Acad. Sci. USA
, vol.107
, pp. 3505-3510
-
-
Li, L.1
Fang, C.J.2
Ryan, J.C.3
-
137
-
-
79952996094
-
Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation
-
Liu B., Moloney A., Meehan S. et al. (2011) Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J. Biol. Chem. 286, 4248–4256.
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 4248-4256
-
-
Liu, B.1
Moloney, A.2
Meehan, S.3
-
138
-
-
0029153619
-
Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions
-
Loeffler D. A., Connor J. R., Juneau P. L., Snyder B. S., Kanaley L., DeMaggio A. J., Nguyen H., Brickman C. M. and LeWitt P. A. (1995) Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J. Neurochem. 65, 710–724.
-
(1995)
J. Neurochem.
, vol.65
, pp. 710-724
-
-
Loeffler, D.A.1
Connor, J.R.2
Juneau, P.L.3
Snyder, B.S.4
Kanaley, L.5
DeMaggio, A.J.6
Nguyen, H.7
Brickman, C.M.8
LeWitt, P.A.9
-
139
-
-
0036884733
-
Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein
-
Lotharius J. and Brundin P. (2002) Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3, 932–942.
-
(2002)
Nat. Rev. Neurosci.
, vol.3
, pp. 932-942
-
-
Lotharius, J.1
Brundin, P.2
-
140
-
-
0032507975
-
Copper, iron and zinc in Alzheimer's disease senile plaques
-
Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L. and Markesbery W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47–52.
-
(1998)
J. Neurol. Sci.
, vol.158
, pp. 47-52
-
-
Lovell, M.A.1
Robertson, J.D.2
Teesdale, W.J.3
Campbell, J.L.4
Markesbery, W.R.5
-
141
-
-
12844250694
-
Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3
-
discussion 673-681
-
Lovell M. A., Xiong S., Xie C., Davies P. and Markesbery W. R. (2004) Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. J. Alzheimers Dis., 6, 659–671; discussion 673-681.
-
(2004)
J. Alzheimers Dis.
, vol.6
, pp. 659-671
-
-
Lovell, M.A.1
Xiong, S.2
Xie, C.3
Davies, P.4
Markesbery, W.R.5
-
142
-
-
84937806176
-
Nitric oxide induces hypoxia ischemic injury in the neonatal brain via the disruption of neuronal iron metabolism
-
Lu Q., Harris V. A., Rafikov R., Sun X., Kumar S. and Black S. M. (2015) Nitric oxide induces hypoxia ischemic injury in the neonatal brain via the disruption of neuronal iron metabolism. Redox. Biol. 6, 112–121.
-
(2015)
Redox. Biol.
, vol.6
, pp. 112-121
-
-
Lu, Q.1
Harris, V.A.2
Rafikov, R.3
Sun, X.4
Kumar, S.5
Black, S.M.6
-
143
-
-
84884777832
-
The correlation of hippocampal T-mapping with neuropsychology test in patients with Alzheimer's disease
-
Luo Z., Zhuang X., Kumar D., Wu X., Yue C., Han C. and Lv J. (2013) The correlation of hippocampal T-mapping with neuropsychology test in patients with Alzheimer's disease. PLoS ONE 8, e76203.
-
(2013)
PLoS ONE
, vol.8
-
-
Luo, Z.1
Zhuang, X.2
Kumar, D.3
Wu, X.4
Yue, C.5
Han, C.6
Lv, J.7
-
144
-
-
16844363930
-
Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights
-
Mancuso M., Davidzon G., Kurlan R. M., Tawil R., Bonilla E., Di Mauro S. and Powers J. M. (2005) Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J. Neuropathol. Exp. Neurol. 64, 280–294.
-
(2005)
J. Neuropathol. Exp. Neurol.
, vol.64
, pp. 280-294
-
-
Mancuso, M.1
Davidzon, G.2
Kurlan, R.M.3
Tawil, R.4
Bonilla, E.5
Di Mauro, S.6
Powers, J.M.7
-
145
-
-
0027327488
-
Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide
-
Mantyh P. W., Ghilardi J. R., Rogers S., DeMaster E., Allen C. J., Stimson E. R. and Maggio J. E. (1993) Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 61, 1171–1174.
-
(1993)
J. Neurochem.
, vol.61
, pp. 1171-1174
-
-
Mantyh, P.W.1
Ghilardi, J.R.2
Rogers, S.3
DeMaster, E.4
Allen, C.J.5
Stimson, E.R.6
Maggio, J.E.7
-
146
-
-
84879053438
-
Ferroportin and exocytoplasmic ferroxidase activity are required for brain microvascular endothelial cell iron efflux
-
McCarthy R. C. and Kosman D. J. (2013) Ferroportin and exocytoplasmic ferroxidase activity are required for brain microvascular endothelial cell iron efflux. J. Biol. Chem. 288, 17932–17940.
-
(2013)
J. Biol. Chem.
, vol.288
, pp. 17932-17940
-
-
McCarthy, R.C.1
Kosman, D.J.2
-
147
-
-
84903720548
-
sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin
-
McCarthy R. C., Park Y. H. and Kosman D. J. (2014) sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin. EMBO Rep. 15, 809–815.
-
(2014)
EMBO Rep.
, vol.15
, pp. 809-815
-
-
McCarthy, R.C.1
Park, Y.H.2
Kosman, D.J.3
-
148
-
-
65449184945
-
Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005
-
McLean E., Cogswell M., Egli I., Wojdyla D. and de Benoist B. (2009) Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 12, 444–454.
-
(2009)
Public Health Nutr.
, vol.12
, pp. 444-454
-
-
McLean, E.1
Cogswell, M.2
Egli, I.3
Wojdyla, D.4
de Benoist, B.5
-
149
-
-
10744223491
-
Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis
-
Meyron-Holtz E. G., Ghosh M. C., Iwai K. et al. (2004) Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 23, 386–395.
-
(2004)
EMBO J.
, vol.23
, pp. 386-395
-
-
Meyron-Holtz, E.G.1
Ghosh, M.C.2
Iwai, K.3
-
150
-
-
0034601251
-
Are hereditary hemochromatosis mutations involved in Alzheimer disease?
-
Moalem S., Percy M. E., Andrews D. F., Kruck T. P., Wong S., Dalton A. J., Mehta P., Fedor B. and Warren A. C. (2000) Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am. J. Med. Genet. 93, 58–66.
-
(2000)
Am. J. Med. Genet.
, vol.93
, pp. 58-66
-
-
Moalem, S.1
Percy, M.E.2
Andrews, D.F.3
Kruck, T.P.4
Wong, S.5
Dalton, A.J.6
Mehta, P.7
Fedor, B.8
Warren, A.C.9
-
152
-
-
0347993815
-
The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain
-
Moos T. and Morgan E. H. (2004) The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain. J. Neurochem. 88, 233–245.
-
(2004)
J. Neurochem.
, vol.88
, pp. 233-245
-
-
Moos, T.1
Morgan, E.H.2
-
153
-
-
33748090285
-
Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1
-
Moos T., Skjoerringe T., Gosk S. and Morgan E. H. (2006) Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. J. Neurochem. 98, 1946–1958.
-
(2006)
J. Neurochem.
, vol.98
, pp. 1946-1958
-
-
Moos, T.1
Skjoerringe, T.2
Gosk, S.3
Morgan, E.H.4
-
155
-
-
84922479199
-
Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease
-
Morris G. P., Clark I. A. and Vissel B. (2014) Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease. Acta. Neuropathol. Commun. 2, 135.
-
(2014)
Acta. Neuropathol. Commun.
, vol.2
, pp. 135
-
-
Morris, G.P.1
Clark, I.A.2
Vissel, B.3
-
156
-
-
50949102412
-
Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network
-
Muckenthaler M. U., Galy B. and Hentze M. W. (2008) Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 28, 197–213.
-
(2008)
Annu. Rev. Nutr.
, vol.28
, pp. 197-213
-
-
Muckenthaler, M.U.1
Galy, B.2
Hentze, M.W.3
-
157
-
-
79951671438
-
Iron loading-induced aggregation and reduction of iron incorporation in heteropolymeric ferritin containing a mutant light chain that causes neurodegeneration
-
Muhoberac B. B., Baraibar M. A. and Vidal R. (2011) Iron loading-induced aggregation and reduction of iron incorporation in heteropolymeric ferritin containing a mutant light chain that causes neurodegeneration. Biochim. Biophys. Acta 1812, 544–548.
-
(2011)
Biochim. Biophys. Acta
, vol.1812
, pp. 544-548
-
-
Muhoberac, B.B.1
Baraibar, M.A.2
Vidal, R.3
-
158
-
-
79955492902
-
HFE gene variants affect iron in the brain
-
Nandar W. and Connor J. R. (2011) HFE gene variants affect iron in the brain. J. Nutr. 141, 729S–739S.
-
(2011)
J. Nutr.
, vol.141
, pp. 729S-739S
-
-
Nandar, W.1
Connor, J.R.2
-
159
-
-
77954104112
-
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update
-
Nuytemans K., Theuns J., Cruts M. and Van Broeckhoven C. (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum. Mutat. 31, 763–780.
-
(2010)
Hum. Mutat.
, vol.31
, pp. 763-780
-
-
Nuytemans, K.1
Theuns, J.2
Cruts, M.3
Van Broeckhoven, C.4
-
160
-
-
83455177604
-
Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention
-
Olivieri S., Conti A., Iannaccone S. et al. (2011) Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention. J. Neurosci. 31, 18568–18577.
-
(2011)
J. Neurosci.
, vol.31
, pp. 18568-18577
-
-
Olivieri, S.1
Conti, A.2
Iannaccone, S.3
-
161
-
-
4444273210
-
Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models
-
Ortiz E., Pasquini J. M., Thompson K., Felt B., Butkus G., Beard J. and Connor J. R. (2004) Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J. Neurosci. Res. 77, 681–689.
-
(2004)
J. Neurosci. Res.
, vol.77
, pp. 681-689
-
-
Ortiz, E.1
Pasquini, J.M.2
Thompson, K.3
Felt, B.4
Butkus, G.5
Beard, J.6
Connor, J.R.7
-
162
-
-
0036703490
-
Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury
-
Patel B. N., Dunn R. J., Jeong S. Y., Zhu Q., Julien J. P. and David S. (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22, 6578–6586.
-
(2002)
J. Neurosci.
, vol.22
, pp. 6578-6586
-
-
Patel, B.N.1
Dunn, R.J.2
Jeong, S.Y.3
Zhu, Q.4
Julien, J.P.5
David, S.6
-
163
-
-
47849117346
-
Involvement of ApoE E4 and H63D in sporadic Alzheimer's disease in a folate-supplemented Ontario population
-
Percy M., Moalem S., Garcia A. et al. (2008) Involvement of ApoE E4 and H63D in sporadic Alzheimer's disease in a folate-supplemented Ontario population. J. Alzheimers Dis. 14, 69–84.
-
(2008)
J. Alzheimers Dis.
, vol.14
, pp. 69-84
-
-
Percy, M.1
Moalem, S.2
Garcia, A.3
-
164
-
-
9644270708
-
Dementia-free centenarians
-
Perls T. (2004) Dementia-free centenarians. Exp. Gerontol. 39, 1587–1593.
-
(2004)
Exp. Gerontol.
, vol.39
, pp. 1587-1593
-
-
Perls, T.1
-
165
-
-
18744374615
-
Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?
-
Perry G., Nunomura A., Hirai K. et al. (2002) Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic. Biol. Med. 33, 1475–1479.
-
(2002)
Free Radic. Biol. Med.
, vol.33
, pp. 1475-1479
-
-
Perry, G.1
Nunomura, A.2
Hirai, K.3
-
166
-
-
67349165691
-
MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods
-
Pfefferbaum A., Adalsteinsson E., Rohlfing T. and Sullivan E. V. (2009) MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. NeuroImage 47, 493–500.
-
(2009)
NeuroImage
, vol.47
, pp. 493-500
-
-
Pfefferbaum, A.1
Adalsteinsson, E.2
Rohlfing, T.3
Sullivan, E.V.4
-
167
-
-
84879529900
-
Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study
-
Pichler I., Del Greco M. F., Gogele M. et al. (2013) Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study. PLoS Med. 10, e1001462.
-
(2013)
PLoS Med.
, vol.10
-
-
Pichler, I.1
Del Greco, M.F.2
Gogele, M.3
-
168
-
-
0037462675
-
Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones
-
Pietsch E. C., Chan J. Y., Torti F. M. and Torti S. V. (2003) Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J. Biol. Chem. 278, 2361–2369.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 2361-2369
-
-
Pietsch, E.C.1
Chan, J.Y.2
Torti, F.M.3
Torti, S.V.4
-
169
-
-
0030744876
-
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
-
Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045–2047.
-
(1997)
Science
, vol.276
, pp. 2045-2047
-
-
Polymeropoulos, M.H.1
Lavedan, C.2
Leroy, E.3
-
170
-
-
33747834381
-
p53-mediated apoptosis, neuroglobin overexpression, and globin deposits in a patient with hereditary ferritinopathy
-
Powers J. M. (2006) p53-mediated apoptosis, neuroglobin overexpression, and globin deposits in a patient with hereditary ferritinopathy. J. Neuropathol. Exp. Neurol. 65, 716–721.
-
(2006)
J. Neuropathol. Exp. Neurol.
, vol.65
, pp. 716-721
-
-
Powers, J.M.1
-
171
-
-
67349184808
-
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease
-
Price J. L., McKeel D. W. Jr, Buckles V. D. et al. (2009) Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol. Aging 30, 1026–1036.
-
(2009)
Neurobiol. Aging
, vol.30
, pp. 1026-1036
-
-
Price, J.L.1
McKeel, D.W.2
Buckles, V.D.3
-
172
-
-
0029984860
-
Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity
-
Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L. and Dawson T. M. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl Acad. Sci. USA 93, 4565–4571.
-
(1996)
Proc. Natl Acad. Sci. USA
, vol.93
, pp. 4565-4571
-
-
Przedborski, S.1
Jackson-Lewis, V.2
Yokoyama, R.3
Shibata, T.4
Dawson, V.L.5
Dawson, T.M.6
-
173
-
-
0041819578
-
Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE
-
Pulliam J. F., Jennings C. D., Kryscio R. J., Davis D. G., Wilson D., Montine T. J., Schmitt F. A. and Markesbery W. R. (2003) Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE. Am. J. Med. Genet. B Neuropsychiatr. Genet. 119B, 48–53.
-
(2003)
Am. J. Med. Genet. B Neuropsychiatr. Genet.
, vol.119B
, pp. 48-53
-
-
Pulliam, J.F.1
Jennings, C.D.2
Kryscio, R.J.3
Davis, D.G.4
Wilson, D.5
Montine, T.J.6
Schmitt, F.A.7
Markesbery, W.R.8
-
174
-
-
84930077320
-
High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry
-
Pyatigorskaya N., Sharman M., Corvol J. C. et al. (2015) High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry. Mov. Disord. 30, 1077–1084.
-
(2015)
Mov. Disord.
, vol.30
, pp. 1077-1084
-
-
Pyatigorskaya, N.1
Sharman, M.2
Corvol, J.C.3
-
175
-
-
0029029016
-
Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes
-
Qi Y., Jamindar T. M. and Dawson G. (1995) Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes. J. Neurochem. 64, 2458–2464.
-
(1995)
J. Neurochem.
, vol.64
, pp. 2458-2464
-
-
Qi, Y.1
Jamindar, T.M.2
Dawson, G.3
-
176
-
-
80455155223
-
Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2’ mapping
-
Qin Y., Zhu W., Zhan C., Zhao L., Wang J., Tian Q. and Wang W. (2011) Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2’ mapping. J. Huazhong Univ. Sci. Technolog Med. Sci. 31, 578–585.
-
(2011)
J. Huazhong Univ. Sci. Technolog Med. Sci.
, vol.31
, pp. 578-585
-
-
Qin, Y.1
Zhu, W.2
Zhan, C.3
Zhao, L.4
Wang, J.5
Tian, Q.6
Wang, W.7
-
177
-
-
84884696816
-
Perinatal iron deficiency and neurocognitive development
-
Radlowski E. C. and Johnson R. W. (2013) Perinatal iron deficiency and neurocognitive development. Front. Hum. Neurosci. 7, 585.
-
(2013)
Front. Hum. Neurosci.
, vol.7
, pp. 585
-
-
Radlowski, E.C.1
Johnson, R.W.2
-
178
-
-
84874284249
-
Systemic and cellular consequences of macrophage control of iron metabolism
-
Recalcati S., Locati M. and Cairo G. (2012) Systemic and cellular consequences of macrophage control of iron metabolism. Semin. Immunol. 24, 393–398.
-
(2012)
Semin. Immunol.
, vol.24
, pp. 393-398
-
-
Recalcati, S.1
Locati, M.2
Cairo, G.3
-
179
-
-
77950538370
-
Cognition, reserve, and amyloid deposition in normal aging
-
Rentz D. M., Locascio J. J., Becker J. A., Moran E. K., Eng E., Buckner R. L., Sperling R. A. and Johnson K. A. (2010) Cognition, reserve, and amyloid deposition in normal aging. Ann. Neurol. 67, 353–364.
-
(2010)
Ann. Neurol.
, vol.67
, pp. 353-364
-
-
Rentz, D.M.1
Locascio, J.J.2
Becker, J.A.3
Moran, E.K.4
Eng, E.5
Buckner, R.L.6
Sperling, R.A.7
Johnson, K.A.8
-
180
-
-
10744224267
-
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial
-
Ritchie C. W., Bush A. I., Mackinnon A. et al. (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 60, 1685–1691.
-
(2003)
Arch. Neurol.
, vol.60
, pp. 1685-1691
-
-
Ritchie, C.W.1
Bush, A.I.2
Mackinnon, A.3
-
181
-
-
78649663704
-
Differential effects of age and history of hypertension on regional brain volumes and iron
-
Rodrigue K. M., Haacke E. M. and Raz N. (2011) Differential effects of age and history of hypertension on regional brain volumes and iron. NeuroImage 54, 750–759.
-
(2011)
NeuroImage
, vol.54
, pp. 750-759
-
-
Rodrigue, K.M.1
Haacke, E.M.2
Raz, N.3
-
182
-
-
0033525735
-
Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5’-untranslated region sequences
-
Rogers J. T., Leiter L. M., McPhee J., Cahill C. M., Zhan S. S., Potter H. and Nilsson L. N. (1999) Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5’-untranslated region sequences. J. Biol. Chem. 274, 6421–6431.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 6421-6431
-
-
Rogers, J.T.1
Leiter, L.M.2
McPhee, J.3
Cahill, C.M.4
Zhan, S.S.5
Potter, H.6
Nilsson, L.N.7
-
183
-
-
0347928847
-
An iron-responsive element type II in the 5’-untranslated region of the Alzheimer's amyloid precursor protein transcript
-
Rogers J. T., Randall J. D., Cahill C. M. et al. (2002) An iron-responsive element type II in the 5’-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 277, 45518–45528.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 45518-45528
-
-
Rogers, J.T.1
Randall, J.D.2
Cahill, C.M.3
-
184
-
-
0030005627
-
Apolipoprotein E alleles as risk factors in Alzheimer's disease
-
Roses A. D. (1996) Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu. Rev. Med. 47, 387–400.
-
(1996)
Annu. Rev. Med.
, vol.47
, pp. 387-400
-
-
Roses, A.D.1
-
185
-
-
74449085808
-
Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins
-
Rouault T. A., Zhang D. L. and Jeong S. Y. (2009) Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins. Metab. Brain Dis. 24, 673–684.
-
(2009)
Metab. Brain Dis.
, vol.24
, pp. 673-684
-
-
Rouault, T.A.1
Zhang, D.L.2
Jeong, S.Y.3
-
186
-
-
84890115517
-
Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription
-
Ryan S. D., Dolatabadi N., Chan S. F. et al. (2013) Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription. Cell 155, 1351–1364.
-
(2013)
Cell
, vol.155
, pp. 1351-1364
-
-
Ryan, S.D.1
Dolatabadi, N.2
Chan, S.F.3
-
187
-
-
57449092273
-
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
-
Salazar J., Mena N., Hunot S. et al. (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 18578–18583.
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, pp. 18578-18583
-
-
Salazar, J.1
Mena, N.2
Hunot, S.3
-
188
-
-
0034964682
-
The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease
-
Sampietro M., Caputo L., Casatta A., Meregalli M., Pellagatti A., Tagliabue J., Annoni G. and Vergani C. (2001) The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. Neurobiol. Aging 22, 563–568.
-
(2001)
Neurobiol. Aging
, vol.22
, pp. 563-568
-
-
Sampietro, M.1
Caputo, L.2
Casatta, A.3
Meregalli, M.4
Pellagatti, A.5
Tagliabue, J.6
Annoni, G.7
Vergani, C.8
-
189
-
-
0029981111
-
Differential expression of the heavy-chain ferritin gene in non-adhered and adhered oligodendrocytes
-
Sanyal B., Polak P. E. and Szuchet S. (1996) Differential expression of the heavy-chain ferritin gene in non-adhered and adhered oligodendrocytes. J. Neurosci. Res. 46, 187–197.
-
(1996)
J. Neurosci. Res.
, vol.46
, pp. 187-197
-
-
Sanyal, B.1
Polak, P.E.2
Szuchet, S.3
-
190
-
-
0027327267
-
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
-
Saunders A. M., Strittmatter W. J., Schmechel D. et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467–1472.
-
(1993)
Neurology
, vol.43
, pp. 1467-1472
-
-
Saunders, A.M.1
Strittmatter, W.J.2
Schmechel, D.3
-
191
-
-
29844450760
-
Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment
-
Schipper H. M., Bennett D. A., Liberman A., Bienias J. L., Schneider J. A., Kelly J. and Arvanitakis Z. (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol. Aging 27, 252–261.
-
(2006)
Neurobiol. Aging
, vol.27
, pp. 252-261
-
-
Schipper, H.M.1
Bennett, D.A.2
Liberman, A.3
Bienias, J.L.4
Schneider, J.A.5
Kelly, J.6
Arvanitakis, Z.7
-
192
-
-
84875722419
-
Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA)
-
Schneider S. A. and Bhatia K. P. (2013) Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA). J. Neural. Transm. 120, 695–703.
-
(2013)
J. Neural. Transm.
, vol.120
, pp. 695-703
-
-
Schneider, S.A.1
Bhatia, K.P.2
-
194
-
-
54049133647
-
A potential pathogenetic role of iron in Alzheimer's disease
-
Silvestri L. and Camaschella C. (2008) A potential pathogenetic role of iron in Alzheimer's disease. J. Cell Mol. Med. 12, 1548–1550.
-
(2008)
J. Cell Mol. Med.
, vol.12
, pp. 1548-1550
-
-
Silvestri, L.1
Camaschella, C.2
-
195
-
-
38349194098
-
Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
-
Silvestri L., Pagani A. and Camaschella C. (2008) Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 111, 924–931.
-
(2008)
Blood
, vol.111
, pp. 924-931
-
-
Silvestri, L.1
Pagani, A.2
Camaschella, C.3
-
196
-
-
84920646171
-
A novel model for brain iron uptake: introducing the concept of regulation
-
Simpson I. A., Ponnuru P., Klinger M. E., Myers R. L., Devraj K., Coe C. L., Lubach G. R., Carruthers A. and Connor J. R. (2015) A novel model for brain iron uptake: introducing the concept of regulation. J. Cereb. Blood Flow Metab. 35, 48–57.
-
(2015)
J. Cereb. Blood Flow Metab.
, vol.35
, pp. 48-57
-
-
Simpson, I.A.1
Ponnuru, P.2
Klinger, M.E.3
Myers, R.L.4
Devraj, K.5
Coe, C.L.6
Lubach, G.R.7
Carruthers, A.8
Connor, J.R.9
-
197
-
-
84894475785
-
Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities
-
Singh N., Haldar S., Tripathi A. K. et al. (2014) Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid. Redox Signal. 20, 1324–1363.
-
(2014)
Antioxid. Redox Signal.
, vol.20
, pp. 1324-1363
-
-
Singh, N.1
Haldar, S.2
Tripathi, A.K.3
-
198
-
-
0030885482
-
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
-
Smith M. A., Harris P. L., Sayre L. M. and Perry G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl Acad. Sci. USA 94, 9866–9868.
-
(1997)
Proc. Natl Acad. Sci. USA
, vol.94
, pp. 9866-9868
-
-
Smith, M.A.1
Harris, P.L.2
Sayre, L.M.3
Perry, G.4
-
199
-
-
34247247314
-
Brain structural alterations before mild cognitive impairment
-
Smith C. D., Chebrolu H., Wekstein D. R., Schmitt F. A., Jicha G. A., Cooper G. and Markesbery W. R. (2007) Brain structural alterations before mild cognitive impairment. Neurology 68, 1268–1273.
-
(2007)
Neurology
, vol.68
, pp. 1268-1273
-
-
Smith, C.D.1
Chebrolu, H.2
Wekstein, D.R.3
Schmitt, F.A.4
Jicha, G.A.5
Cooper, G.6
Markesbery, W.R.7
-
200
-
-
75149152568
-
Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment
-
Smith M. A., Zhu X., Tabaton M. et al. (2010) Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 19, 363–372.
-
(2010)
J. Alzheimers Dis.
, vol.19
, pp. 363-372
-
-
Smith, M.A.1
Zhu, X.2
Tabaton, M.3
-
201
-
-
67349112729
-
Iron, the substantia nigra and related neurological disorders
-
Snyder A. M. and Connor J. R. (2009) Iron, the substantia nigra and related neurological disorders. Biochim. Biophys. Acta 1790, 606–614.
-
(2009)
Biochim. Biophys. Acta
, vol.1790
, pp. 606-614
-
-
Snyder, A.M.1
Connor, J.R.2
-
202
-
-
0023804321
-
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
-
Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G. P., Hebenstreit G. and Youdim M. B. (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural. Transm. 74, 199–205.
-
(1988)
J. Neural. Transm.
, vol.74
, pp. 199-205
-
-
Sofic, E.1
Riederer, P.2
Heinsen, H.3
Beckmann, H.4
Reynolds, G.P.5
Hebenstreit, G.6
Youdim, M.B.7
-
203
-
-
0025963530
-
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains
-
Sofic E., Paulus W., Jellinger K., Riederer P. and Youdim M. B. (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J. Neurochem. 56, 978–982.
-
(1991)
J. Neurochem.
, vol.56
, pp. 978-982
-
-
Sofic, E.1
Paulus, W.2
Jellinger, K.3
Riederer, P.4
Youdim, M.B.5
-
204
-
-
0026794561
-
Iron uptake in relation to transferrin degradation in brain and other tissues of rats
-
Strahan M. E., Crowe A. and Morgan E. H. (1992) Iron uptake in relation to transferrin degradation in brain and other tissues of rats. Am. J. Physiol. 263, R924–R929.
-
(1992)
Am. J. Physiol.
, vol.263
, pp. R924-R929
-
-
Strahan, M.E.1
Crowe, A.2
Morgan, E.H.3
-
205
-
-
84916882462
-
Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis
-
Tao Y., Wang Y., Rogers J. T. and Wang F. (2014) Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis. J. Alzheimers Dis. 42, 679–690.
-
(2014)
J. Alzheimers Dis.
, vol.42
, pp. 679-690
-
-
Tao, Y.1
Wang, Y.2
Rogers, J.T.3
Wang, F.4
-
206
-
-
56749156761
-
Tim-2 is the receptor for H-ferritin on oligodendrocytes
-
Todorich B., Zhang X., Slagle-Webb B., Seaman W. E. and Connor J. R. (2008) Tim-2 is the receptor for H-ferritin on oligodendrocytes. J. Neurochem. 107, 1495–1505.
-
(2008)
J. Neurochem.
, vol.107
, pp. 1495-1505
-
-
Todorich, B.1
Zhang, X.2
Slagle-Webb, B.3
Seaman, W.E.4
Connor, J.R.5
-
207
-
-
79954616688
-
H-ferritin is the major source of iron for oligodendrocytes
-
Todorich B., Zhang X. and Connor J. R. (2011) H-ferritin is the major source of iron for oligodendrocytes. Glia 59, 927–935.
-
(2011)
Glia
, vol.59
, pp. 927-935
-
-
Todorich, B.1
Zhang, X.2
Connor, J.R.3
-
208
-
-
0035941201
-
Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure
-
Uversky V. N., Li J. and Fink A. L. (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 276, 44284–44296.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 44284-44296
-
-
Uversky, V.N.1
Li, J.2
Fink, A.L.3
-
209
-
-
2442668926
-
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
-
Valente E. M., Abou-Sleiman P. M., Caputo V. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158–1160.
-
(2004)
Science
, vol.304
, pp. 1158-1160
-
-
Valente, E.M.1
Abou-Sleiman, P.M.2
Caputo, V.3
-
210
-
-
84862845774
-
Overexpression of human wild-type amyloid-beta protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cells
-
Wan L., Nie G., Zhang J. and Zhao B. (2012) Overexpression of human wild-type amyloid-beta protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cells. J. Alzheimers Dis. 30, 523–530.
-
(2012)
J. Alzheimers Dis.
, vol.30
, pp. 523-530
-
-
Wan, L.1
Nie, G.2
Zhang, J.3
Zhao, B.4
-
211
-
-
79952162002
-
Regulation of cellular iron metabolism
-
Wang J. and Pantopoulos K. (2011) Regulation of cellular iron metabolism. Biochem. J. 434, 365–381.
-
(2011)
Biochem. J.
, vol.434
, pp. 365-381
-
-
Wang, J.1
Pantopoulos, K.2
-
212
-
-
84911913522
-
Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice
-
Wang D., Hui Y., Peng Y. et al. (2015) Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice. J. Alzheimers Dis. 43, 519–534.
-
(2015)
J. Alzheimers Dis.
, vol.43
, pp. 519-534
-
-
Wang, D.1
Hui, Y.2
Peng, Y.3
-
213
-
-
84907999177
-
The role of iron in brain ageing and neurodegenerative disorders
-
Ward R. J., Zucca F. A., Duyn J. H., Crichton R. R. and Zecca L. (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 13, 1045–1060.
-
(2014)
Lancet Neurol.
, vol.13
, pp. 1045-1060
-
-
Ward, R.J.1
Zucca, F.A.2
Duyn, J.H.3
Crichton, R.R.4
Zecca, L.5
-
214
-
-
0025353319
-
Interleukin 1 induces ferritin heavy chain in human muscle cells
-
Wei Y., Miller S. C., Tsuji Y., Torti S. V. and Torti F. M. (1990) Interleukin 1 induces ferritin heavy chain in human muscle cells. Biochem. Biophys. Res. Commun. 169, 289–296.
-
(1990)
Biochem. Biophys. Res. Commun.
, vol.169
, pp. 289-296
-
-
Wei, Y.1
Miller, S.C.2
Tsuji, Y.3
Torti, S.V.4
Torti, F.M.5
-
215
-
-
84884901205
-
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
-
Weinreb O., Mandel S., Youdim M. B. and Amit T. (2013) Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators. Free Radic. Biol. Med. 62, 52–64.
-
(2013)
Free Radic. Biol. Med.
, vol.62
, pp. 52-64
-
-
Weinreb, O.1
Mandel, S.2
Youdim, M.B.3
Amit, T.4
-
216
-
-
77955600573
-
Iron homeostasis and the inflammatory response
-
Wessling-Resnick M. (2010) Iron homeostasis and the inflammatory response. Annu. Rev. Nutr. 30, 105–122.
-
(2010)
Annu. Rev. Nutr.
, vol.30
, pp. 105-122
-
-
Wessling-Resnick, M.1
-
217
-
-
58149084932
-
Chemistry and antihypertensive effects of tempol and other nitroxides
-
Wilcox C. S. and Pearlman A. (2008) Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol. Rev. 60, 418–469.
-
(2008)
Pharmacol. Rev.
, vol.60
, pp. 418-469
-
-
Wilcox, C.S.1
Pearlman, A.2
-
218
-
-
84902096220
-
The molecular biology of human iron metabolism
-
Winter W. E., Bazydlo L. A. and Harris N. S. (2014) The molecular biology of human iron metabolism. Lab. Med. 45, 92–102.
-
(2014)
Lab. Med.
, vol.45
, pp. 92-102
-
-
Winter, W.E.1
Bazydlo, L.A.2
Harris, N.S.3
-
219
-
-
84901058201
-
The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders
-
Wong B. X. and Duce J. A. (2014) The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders. Fron. Pharmacol. 5, 81.
-
(2014)
Fron. Pharmacol.
, vol.5
, pp. 81
-
-
Wong, B.X.1
Duce, J.A.2
-
220
-
-
84907148276
-
A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe(2 +) under physiologically relevant conditions
-
Wong B. X., Ayton S., Lam L. Q., Lei P., Adlard P. A., Bush A. I. and Duce J. A. (2014a) A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe(2 +) under physiologically relevant conditions. Biochim. Biophys. Acta 1840, 3299–3310.
-
(2014)
Biochim. Biophys. Acta
, vol.1840
, pp. 3299-3310
-
-
Wong, B.X.1
Ayton, S.2
Lam, L.Q.3
Lei, P.4
Adlard, P.A.5
Bush, A.I.6
Duce, J.A.7
-
221
-
-
84914693430
-
beta-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin
-
Wong B. X., Tsatsanis A., Lim L. Q., Adlard P. A., Bush A. I. and Duce J. A. (2014b) beta-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS ONE 9, e114174.
-
(2014)
PLoS ONE
, vol.9
-
-
Wong, B.X.1
Tsatsanis, A.2
Lim, L.Q.3
Adlard, P.A.4
Bush, A.I.5
Duce, J.A.6
-
222
-
-
10744219518
-
Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier
-
Wu L. J., Leenders A. G., Cooperman S. et al. (2004) Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res. 1001, 108–117.
-
(2004)
Brain Res.
, vol.1001
, pp. 108-117
-
-
Wu, L.J.1
Leenders, A.G.2
Cooperman, S.3
-
223
-
-
33646911081
-
Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus
-
Xu Q., Bernardo A., Walker D., Kanegawa T., Mahley R. W. and Huang Y. (2006) Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 26, 4985–4994.
-
(2006)
J. Neurosci.
, vol.26
, pp. 4985-4994
-
-
Xu, Q.1
Bernardo, A.2
Walker, D.3
Kanegawa, T.4
Mahley, R.W.5
Huang, Y.6
-
224
-
-
0036724204
-
Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease
-
Yamamoto A., Shin R. W., Hasegawa K., Naiki H., Sato H., Yoshimasu F. and Kitamoto T. (2002) Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J. Neurochem. 82, 1137–1147.
-
(2002)
J. Neurochem.
, vol.82
, pp. 1137-1147
-
-
Yamamoto, A.1
Shin, R.W.2
Hasegawa, K.3
Naiki, H.4
Sato, H.5
Yoshimasu, F.6
Kitamoto, T.7
-
225
-
-
0028006428
-
Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain
-
Zecca L., Pietra R., Goj C., Mecacci C., Radice D. and Sabbioni E. (1994) Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain. J. Neurochem. 62, 1097–1101.
-
(1994)
J. Neurochem.
, vol.62
, pp. 1097-1101
-
-
Zecca, L.1
Pietra, R.2
Goj, C.3
Mecacci, C.4
Radice, D.5
Sabbioni, E.6
-
226
-
-
0035103932
-
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes
-
Zecca L., Gallorini M., Schunemann V., Trautwein A. X., Gerlach M., Riederer P., Vezzoni P. and Tampellini D. (2001) Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J. Neurochem. 76, 1766–1773.
-
(2001)
J. Neurochem.
, vol.76
, pp. 1766-1773
-
-
Zecca, L.1
Gallorini, M.2
Schunemann, V.3
Trautwein, A.X.4
Gerlach, M.5
Riederer, P.6
Vezzoni, P.7
Tampellini, D.8
-
227
-
-
3042793602
-
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
-
Zecca L., Stroppolo A., Gatti A. et al. (2004a) The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc. Natl Acad. Sci. USA 101, 9843–9848.
-
(2004)
Proc. Natl Acad. Sci. USA
, vol.101
, pp. 9843-9848
-
-
Zecca, L.1
Stroppolo, A.2
Gatti, A.3
-
228
-
-
8344265251
-
Iron, brain ageing and neurodegenerative disorders
-
Zecca L., Youdim M. B., Riederer P., Connor J. R. and Crichton R. R. (2004b) Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863–873.
-
(2004)
Nat. Rev. Neurosci.
, vol.5
, pp. 863-873
-
-
Zecca, L.1
Youdim, M.B.2
Riederer, P.3
Connor, J.R.4
Crichton, R.R.5
-
229
-
-
33750535445
-
Cellular iron status influences the functional relationship between microglia and oligodendrocytes
-
Zhang X., Surguladze N., Slagle-Webb B., Cozzi A. and Connor J. R. (2006) Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54, 795–804.
-
(2006)
Glia
, vol.54
, pp. 795-804
-
-
Zhang, X.1
Surguladze, N.2
Slagle-Webb, B.3
Cozzi, A.4
Connor, J.R.5
-
230
-
-
84904738032
-
The physiological functions of iron regulatory proteins in iron homeostasis - an update
-
Zhang D. L., Ghosh M. C. and Rouault T. A. (2014) The physiological functions of iron regulatory proteins in iron homeostasis - an update. Front. Pharmacol. 5, 124.
-
(2014)
Front. Pharmacol.
, vol.5
, pp. 124
-
-
Zhang, D.L.1
Ghosh, M.C.2
Rouault, T.A.3
-
231
-
-
77950118979
-
Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease
-
Zhu W. Z., Zhong W. D., Wang W., Zhan C. J., Wang C. Y., Qi J. P., Wang J. Z. and Lei T. (2009) Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 253, 497–504.
-
(2009)
Radiology
, vol.253
, pp. 497-504
-
-
Zhu, W.Z.1
Zhong, W.D.2
Wang, W.3
Zhan, C.J.4
Wang, C.Y.5
Qi, J.P.6
Wang, J.Z.7
Lei, T.8
-
232
-
-
84891859053
-
Neuromelanin of the human substantia nigra: an update
-
Zucca F. A., Basso E., Cupaioli F. A., Ferrari E., Sulzer D., Casella L. and Zecca L. (2014) Neuromelanin of the human substantia nigra: an update. Neurotox. Res. 25, 13–23.
-
(2014)
Neurotox. Res.
, vol.25
, pp. 13-23
-
-
Zucca, F.A.1
Basso, E.2
Cupaioli, F.A.3
Ferrari, E.4
Sulzer, D.5
Casella, L.6
Zecca, L.7
|